Patents by Inventor Kay Elizabeth Murphy

Kay Elizabeth Murphy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds
    Publication number: 20030064481
    Abstract: A soluble protein having IL4 and/or IL13 antagonist or partial antagonist activity comprises an IL4 mutant or variant fused to least one human immunoglobulin constant domain or fragment thereof.
    Type: Application
    Filed: January 16, 2002
    Publication date: April 3, 2003
    Applicant: SmithKline Beecham Corporation and SmithKline Beecham p.l.c.
    Inventors: Michael Joseph Browne, Peter Ronald Young, Allan Richard Shatzman, Kay Elizabeth Murphy, Conrad Gerald Chapman, Helen Elizabeth Clinkenbeard
  • Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists and immunoglobulins
    Patent number: 5783181
    Abstract: A soluble protein having IL4 and/or IL13 antagonist or partial antagonist activity comprises an IL4 mutant or variant fused to least one human immunoglobulin constant domain or fragment thereof.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 21, 1998
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Michael Joseph Browne, Peter Ronald Young, Allan Richard Shatzman, Kay Elizabeth Murphy, Conrad Gerald Chapman, Helen Elizabeth Clinkenbeard